The nutrient choline – shown to have long-term benefits for children whose mothers consume it during pregnancy – also helps the body more efficiently use an omega 3 fatty acid that is essential for fetal development.
Some countries use a relatively straightforward cost-effectiveness analysis to decide whether to green light insurance coverage of prescription drugs. That can prevent new drugs from entering the market that would be highly sought after by patients who value costlier care.
Disruption of the circadian clocks that keep the body and its cells entrained to the 24-hour day-night cycle plays a critical role in weight gain, according to a pair of studies by Weill Cornell Medicine investigators.
A new study finds that certain species of bacteria in the gut interact with and help balance levels of dietary cholesterol by using it to create a molecule that plays important roles in human health.
Members of Cornell’s Action Research Collaborative joined representatives from New York City agencies at a symposium Aug. 11 to discuss innovative new solutions aimed at dismantling the systemic racism that has led to inequities around food, nutrition, education, health and employment.
Nancy Schlichting '79 is a pioneering leader the healthcare industry, an enthusiastic supporter of the Sloan Program in Health Administration and now an honoree in the Modern Healthcare Hall of Fame.
“Threads of Life, Loss, and Love: An HIV/AIDS Story” runs Aug. 15 through Dec. 2 in the Human Ecology Commons and Level T display cases and features garments, accessories, documents, ephemera and film from the collection of Sylvia Goldstaub.
By the end of this century, Cornell’s Flavio Lehner and others said that megadroughts – extended drought events that can last two decades – will be more severe and longer in the western U.S. than they are today.
North American white-tailed deer – shown in 2021 surveys of five states to have SARS-CoV-2 infection rates of up to 40% – shed and transmit the virus for up to five days once infected, according to a new study.
The study suggests that a unique set of regulatory networks controlled by neurons in the gut may be viable targets for future drug therapies to combat chronic inflammatory diseases including asthma, allergy and inflammatory bowel disease.